Sore throat and fever are common presentations in general practice. While usually caused by viral infection and self-limiting, persistent or worsening symptoms, especially in patients with comorbidities, require investigation for sinister causes.
The following two cases involve patients presenting with nonspecific upper respiratory tract infection symptoms who were later diagnosed with drug-induced agranulocytosis caused by an anti-thyroid medication (Carbimazole). In both instances, the Medical Council of Hong Kong (MCHK) conducted disciplinary inquiries and issued removal orders against the attending doctors.
Patient A consulted Dr. H for a thyroid condition and was prescribed Carbimazole. During follow-ups, the patient developed eye redness, epistaxis, urticaria, shortness of breath, and tachycardia. Despite these warning signs, Dr. H increased the Carbimazole dosage. When the patient returned with a sore throat and gum infection, Dr. H prescribed antibiotics. Patient A was subsequently hospitalised with sepsis secondary to drug-induced agranulocytosis and hyperthyroidism, requiring prolonged recovery. The MCHK found Dr. H failed to inform the patient of Carbimazole’s potential side effects prior to prescription.
Patient B presented to Dr. L with fever and sore throat and informed Dr. L that she was taking thyroid medication. Dr. L diagnosed acute tonsillitis and prescribed antibiotics without inquiring further about the thyroid regimen. When symptoms persisted and mouth sores developed, Dr. L prescribed medications including Prednisolone (a steroid). The patient later coughed up blood-stained sputum, was admitted to the intensive care unit with respiratory failure and ultimately succumbed to multiple organ failure. During the inquiry, Dr. L admitted that he was unaware Carbimazole could cause agranulocytosis. The panel also heavily criticised the inappropriate prescription of steroids, which exacerbated the condition.